与诺基诺相关的精神病不良事件:现实世界的回顾和药监数据库分析
JuanJuan Li1, Xiaohong Yin1, Yang Zhao1
1Department of Pharmacy, Guangyuan Central Hospital, Guanyuan, China.
Expert opinion on drug safety
|July 31, 2024
概括
氨基 (FQs) 可以引起严重的精神不良事件 (AEs),特别是在女性和年龄在19-64岁的成年人中. 早期识别和管理对于安全使用FQ至关重要.
科学领域:
- 药物监测和临床药理学
- 药物安全和风险管理
背景情况:
- 诺基诺 (FQs) 是广谱抗生素,已知可能导致严重不良事件.
- 精神病不良事件 (AEs) 是与FQ使用相关的一个重大问题,需要彻底调查.
研究的目的:
- 评估与FQ相关的精神病学AE的药物监测和临床特征.
- 识别这些事件及时管理的风险因素.
主要方法:
- 利用FDA不良事件报告系统 (FAERS) 数据库进行药监测评估.
- 进行了与FQ使用相关的精神病性副作用报告的回顾性分析.
主要成果:
- 与男性相比,女性 (51.11%-53.23%) 更频繁地报告了精神病性副作用.
- 精神病性AE发生率最高的年龄组是19-44岁和45-64岁.
- 大多数精神病性副作用在FQ给药10天内出现,其中67.74%在药物戒药后3天内消失.
结论:
- 与FQ相关的精神病性副作用是严重的,可能代表不充分报告的安全信号.
- 及时识别和管理这些有害物质对于确保诺基诺的安全使用至关重要.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
12.9K
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.7K
相关概念视频
Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
110
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
110
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
